Powder: -20°C for 3 years | In solvent: -80°C for 1 year
(±)7(8)-DiHDPA is a major metabolite of docosahexaenoic acid that is produced via oxidation by cytochrome P450 epoxygenases. Epoxygenase metabolites of DHA, including (±)7(8)-DiHDPA, suppress aggregation and thromboxane synthesis in isolated platelets.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
50 μg | 35 days | $ 213.00 | |
100 μg | 35 days | $ 363.00 | |
500 μg | 35 days | $ 1,480.00 | |
1 mg | 35 days | $ 2,330.00 |
Description | (±)7(8)-DiHDPA is a major metabolite of docosahexaenoic acid that is produced via oxidation by cytochrome P450 epoxygenases. Epoxygenase metabolites of DHA, including (±)7(8)-DiHDPA, suppress aggregation and thromboxane synthesis in isolated platelets. |
Molecular Weight | 362.51 |
Formula | C22H34O4 |
CAS No. | 168111-93-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMF: 50 mg/mL
DMSO: 50 mg/mL
Ethanol: 50 mg/mL
PBS (pH 7.2): 0.25 mg/mL
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
(±)7(8)-DiHDPA 168111-93-1 (±)7(8)DiHDPA 7(8)-DiHDPA (±)7(8) DiHDPA inhibitor inhibit